We investigated the active components responsible for the anti-allergic effect of Hypsizigus marmoreus on an oxazolone-induced type IV allergy in male ICR mice. Following both an oral administration at a dose of 250 mg/kg body weight and percutaneous administration at 0.10 mg/ear, significant anti-allergic activities were found in the 80% ethanolsoluble fraction (Fr. 1), and the low molecular weight fraction (Fr. 2, below a molecular weight of ca. 12000; Fr. 4, below ca. 3000) prepared from Fr. 1. These fractions included ergosterol, mannitol, and trehalose as antioxidants and/or anti-inflammatory components. The anti-allergic activities of these compounds and methionine were equal to or weaker than those of the fractions. Therefore, the molecular weights of the major active components in Hypsizigus marmoreus are thought to be less than ca. 3000, though ergosterol, mannitol, trehalose, and methionine would not be the main active components.
INTRODUCTION
The increasing prevalence of allergic diseases in the world is worrying. Type IV allergy, one of the * To whom correspondence should be addressed: Department of Chemistry and Biochemistry, Numazu College of Technology, 3600 Ooka, Numazu, Shizuoka 410-8501, Japan. Tel. & Fax: +81-55-926-5861; E-mail: k-yoshino@numazu-ct.ac.jp major types, is known as delayed type hypersensitivity and occurs via a cell-mediated immune reaction. We previously reported that a 99.5% ethanol extract and a boiling water extract of Hypsizigus marmoreus (Peck) Bigel. (bunashimeji), an edible mushroom, inhibited type IV allergy in mice when administered orally and percutaneously. 1) The boiling water extract exhibited significant anti-allergic activity, though it was less active than the 99.5% ethanol extract. Here, we investigated some of the active components in an 80% ethanol extract of Hypsizigus marmoreus for preventive effects on oxazolone-induced type-IV allergy in mice.
MATERIALS AND METHODS

Preparation of Some Fractions from
Hypsizigusmarmoreus --Fractionation of Hypsizigus marmoreus was carried out by the methods shown in Fig. 1 . First, a 80% ethanol extract of the fruiting bodies of Hypsizigus marmoreus supplied by the Japan Agricultural Cooperatives Zennou Nagano (Nagano, Japan) was prepared. One hundred grams of Hypsizigus marmoreus was crushed and extracted under reflux with 700 ml of 80% ethanol at 40 • C for 1 hr. The extract was filtered and the filtrate was lyophilized as fraction 1 (Fr. 1). Then, 10 g of Fr. 1 was suspended in 50 ml of water and dialyzed against 2000 ml of water for 24 hr with a cellulose tube (exclusion molecular weight ca. 12000, Wako Pure Chem. Ind., Osaka, Japan). The dialysate and non-dialysate were lyophilized as fractions 2 (Fr. 2) and 3 (Fr. 3), respectively. Fr. 2 was ultrafiltrated with a Centriplus YM-3 (exclusion molecular weight ca. 3000, Millipore Co., Bedford, MA, U.S.A.). The filtrate and non-filtrate were lyophilized as fractions 4 (Fr. 4) and 5 (Fr. 5). It should be cautious of the molecular weights of substances presumed by dialysis and extra filtration being near values. Determination of Mouse Type IV Allergic Response --Oxazolone-induced edema of the ear was used to evaluate the inhibitory effects of the fractions prepared from Hypsizigus marmoreus on type IV allergy in mice. Oxazolone (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one), a sensitizer for type IV allergies, was purchased from Wako Pure Chem. Ind. Male ICR mice, 4 weeks old, were purchased from Japan SLC, Inc., Shizuoka, Japan. The experiment was carried out as follows. 2, 3) The hair of the abdominal region was carefully cut away, and 0.1 ml of a 0.5% oxazolone solution in ethanol was applied to the skin (sensitization). Five days after the sensitization, 20 µl of a 0.5% oxazolone solution in acetone was applied to both sides of each animal's right ear (challenge). Twenty-four hours after the challenge, the mice were killed under ether anesthesia, and circular samples (5.0 mm in diameter) of both ears were removed using a punching apparatus. The weights of the right (WR) and left (WL) ears were measured. In the case of oral administration, some fractions of Hypsizigus marmoreus, ergosterol (Wako Pure Chem. Ind.), D(−)-mannitol (Wako Pure Chem. Ind.), D(+)-trehalose (Wako Pure Chem. Ind.), and L(−)-methionine (Ajinomoto-Takara Co., Tokyo, Japan) were administered to mice 1 hr before the challenge at doses of 200 and/or 250 mg/kg body weight once a day for 3 days. In the case of percutaneous administration, the samples were added to the challenge solution at doses of 0.10 and/or 0.20 mg/ear and applied to the ear. Hydrocortisone, a well-known steroid-type anti-inflammatory agent, was assayed in the same manner. Control mice were not administered any agents. The number of mice in each group was 5. The anti-allergic activity was evaluated by comparing ear swelling ratios between the treated and control groups. The ear swelling ratio was calculated as follows:
Ear swelling ratio (%)
Throughout the experiment, the animals were handled in accordance with "The Statistical Analysis --The statistical analysis in this study was conducted with the nonparametric Mann-Whitney U test for differences between the groups, and p < 0.05 was considered statistically significant.
RESULTS AND DISCUSSION
Yield and Anti-allergic Activities of Some Fractions of Hypsizigus marmoreus All fractions prepared from Hypsizigus marmoreus were brown powders. The yields of Fr. 1-5, which were expressed as a percentage of the dry weight of Hypsizigus marmoreus, were 25.0, 21.7, 3.3, 11.5, and 10.2%, respectively. Therefore, 86.8% of the components in Fr. 1 had a molecular weight smaller than ca. 12000 and 46.0%, smaller than ca. 3000.
Anti-allergic activities of orally or percutaneously administered Fr. 1-5 of Hypsizigus marmoreus are shown in Fig. 2 . The doses used were 250 mg/kg body weight for the oral route and 0.10 mg/ear for the percutaneous route. In both cases, Fr. 1 had a significant anti-allergic effect on type IV allergy. The rate of inhibition was 56.3% for the oral administration and 66.3% for the percutaneous administration. The anti-allergic activities of Fr. 1 were almost the same as those of the 99.5% ethanol extract of Hypsizigus marmoreus. 1) Though the anti-allergic activity of Fr. 1 was weaker than that of hydrocortisone following the oral administration, it was the same as that of hydrocortisone after the percutaneous administration. Fr. 1 was further fractionated into Fr. 2-5 on the basis of the molecular weights of its components. As shown in Fig. 2 , significant levels of anti-allergic activity were found only in the lower molecular weight fractions, Fr. 2 and 4, on oral and percutaneous administration. These fractions inhibited type IV allergy 52.1 and 45.0% via the oral route and 36.4 and 41.9% via the percutaneous route. These results suggest the molecular weights of the major active components in Fr. 1 of Hypsizigus marmoreus to be less than ca. 3000.
Components in Fr. 1, 2, and 4 of Hypsizigus marmoreus
A type IV allergic response is often accompanied by severe inflammation, an important process in the development of type IV allergies. Active oxygen species, which are produced in activated macrophages and during the enzymatic oxidation of arachidonic acid for the formation of chemical mediators such as leukotrienes and prostaglandins, play an important role in the inflammatory process. It was reported that some antioxidants, tea catechins 4) and superoxide dismutase, 5) could inhibit inflammation. Tea catechins also exhibited anti-allergic effects on type IV allergy in mice. 6) In our other reports, feeding of a diet containing 5-10% dried powder of extracts of Hypsizigus marmoreus increased the antioxidative activity in mouse plasma. 7, 8) Among the components of mushrooms, ergosterol and its peroxides, 9) mannitol, 10) trehalose, 11) and methionine 12) are known to exhibit antioxidative and/or anti-inflammatory activities. It was also reported that Hypsizigus marmoreus contains these compounds. The amount of ergosterol in dry whole fruiting bodies of Hypsizigus marmoreus was 0.43%. 13) The amount of mannitol and trehalose was 1.3 and 2.1%, 14) respectively, and that of free methionine was 0.046%. 15) The molecular weights of ergosterol, mannitol, trehalose, and methionine were less than 3000, being 396.7, 149.2, 342.3, and 182.2, respectively.
Ergosterol, mannitol, and trehalose made up 0.51 ± 0.06, 11.2 ± 0.5, and 26.9 ± 1.8% of Fr. 1, respectively. We compared the difference between the yields and the contents of some components in Fr. 1, which was 80% ethanol extract, and the 99.5% ethanol extract, which was reported in our previous paper. 1) The yield of the 99.5% ethanol extract was 20.2%. The contents of ergosterol, mannitol, and trehalose were 0.79 ± 0.01, 10.8 ± 0.6, and 24.8 ± 0.5% in the 99.5% ethanol extract. The contents of total sugar (measured as glucose by anthronesulfuric acid method) were 38.1 ± 4.9 in Fr. 1 and 43.5 ± 1.4 in the 99.5% ethanol extract. As described above, the anti-allergic activities of Fr. 1 and the 99.5% ethanol extract were also well alike. From these results, we thought the components in Fr. 1 and the 99.5% ethanol extract were much the same. We didn't analyze the methionine content of any fraction of Hypsizigus marmoreus in this study, because it was thought to be extremely low as compared to the amounts of ergosterol, mannitol, and trehalose. Mannitol and trehalose made up 18.8 ± 1.4 and 24.0 ± 0.8% of Fr. 2, and 22.8 ± 1.4 and 26.8 ± 1.2% of Fr. 4, respectively. Ergosterol was not detected in either fraction. These results suggest that the fractionizing process decreased the ergosterol content of the fractions of Hypsizigus marmoreus, increased the mannitol content, and had no effect on the trehalose content.
Anti-allergic Activities of Ergosterol, Mannitol, Trehalose, and Methionine
We examined the anti-allergic effects of these compounds on type IV allergy in mice. The antiallergic activities of ergosterol, mannitol, methionine, and trehalose administered orally at doses of 200 and 250 mg/kg body weight and percutaneously at 0.10 and 0.20 mg/ear are shown in Fig. 3 . Via the oral route, mannitol and trehalose had significant effects at both doses, though ergosterol was effective only at 250 mg/kg. Methionine showed no significant anti-allergic activity at any dose. Via the percutaneous route, mannitol had significant antiallergic effects at both doses, though ergosterol, methionine, and trehalose exhibited significant activity only at 0.20 mg/ear. These results suggest that the oral and percutaneous administration of these compounds was effective against type IV allergy in mice. However, the anti-allergic activities of all these compounds were equal to or weaker than those of Fr. 1, 2, and 4 of Hypsizigus marmoreus at a dose of 250 mg/kg body weight for oral administration and 0.10 mg/ear for percutaneous administration. We examined the effect of the percutaneous admin- istration of a mixture of these components at doses equal to those determined in 0.10 mg of Fr. 1/ear. No significant anti-allergic effect was obtained: the ear swelling ratio was 108 ± 2.02%. The antiallergic activities of ergosterol, mannitol, trehalose, and methionine would insensibly contribute to those of Fr. 1, 2, and 4 of Hypsizigus marmoreus. Except Hypsizigus marmoreus, some components of low molecular weight in various mushrooms were reported as anti-inflammatory and/or antioxidative compounds. The analogues of grifolic acid in Albatrellus dispansus (Lloyd) Canf. et Gilbm. (koumoritake) and the diterpenes such as sarcodonin A and neosarcodonin A in Sarcodon scabrosus (kerouji) were anti-inflammatory compounds. 16, 17) Cycloleucomelone-leucodi-hexaacetate in Boletopsis leucomelas (kurokawa), and grifolin and the analogues of grifolic acid in Albatrellus dispansus (Lloyd) Canf. et Gilbm. and Albatrellus yasudai (numeriaitake) were the inhibitors of 5-lipoxygenase, an enzyme producing leucotrienes. 16, 18) Neogrifolin derivatives in Albatrellus ovinus (ningyoutakemodoki) were antioxidative compounds. 19) All of the molecular weights of these compounds are less than 1000. Though the total amount of ergosterol, mannitol, and trehalose was approximately 39, 43, and 50% in Fr. 1, 2, and 4 of Hypsizigus marmoreus, a small amount of other active components could exist in Fr. 1. On the other hand, the fractionizing process did not increase the anti-allergic activities of the fractions of Hypsizigus marmoreus as shown in Fig. 2. A combination of the effects of some components in Fr. 1 can be anticipated. Further study is needed to identify the other anti-allergic components in the 80% ethanol extract of Hypsizigus marmoreus.
